MA has restated its disappointment at the health department's failure to consult on the attempt to defer submissions from consideration at the March PBAC meeting following the release of advice that shows officials advised Mark Butler it was "critical" to "mitigate" the reputational risks to the government.
'We are very unhappy that we were not consulted as it is an expectation'
December 3, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5, Ep .24
July 17, 2026 - - Podcast -
Ex-Novartis leader joins the board of emerging nuclear medicine company
July 17, 2026 - - Latest News -
It doesn't always feel like it, but make no mistake, this is what winning looks like
July 17, 2026 - - Latest News -
Telix opens Australia's first integrated radiopharmaceutical facility in Melbourne
July 16, 2026 - - Latest News

